158 related articles for article (PubMed ID: 2107596)
1. Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.
Fukao H; Ueshima S; Tanaka N; Okada K; Matsuo O
Thromb Res Suppl; 1990; 10():11-20. PubMed ID: 2107596
[TBL] [Abstract][Full Text] [Related]
2. Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.
Fujii S; Lucore CL; Hopkins WE; Billadello JJ; Sobel BE
Thromb Haemost; 1990 Nov; 64(3):412-9. PubMed ID: 2128971
[TBL] [Abstract][Full Text] [Related]
3. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
[TBL] [Abstract][Full Text] [Related]
4. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
Sakata Y; Okada M; Noro A; Matsuda M
J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelinase and cell-permeable ceramide analogs increase the release of plasminogen activator inhibitor-1 from cultured endothelial cells.
Soeda S; Honda O; Shimeno H; Nagamatsu A
Thromb Res; 1995 Dec; 80(6):509-18. PubMed ID: 8610279
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activator.
Bartha K; Declerck PJ; Moreau H; Nelles L; Collen D
J Biol Chem; 1991 Jan; 266(2):792-7. PubMed ID: 1898737
[TBL] [Abstract][Full Text] [Related]
7. Determinants of induction of increased synthesis of plasminogen activator inhibitor type-1 in human endothelial cells by t-PA.
Fujii S; Sobel BE
Thromb Haemost; 1992 Feb; 67(2):233-8. PubMed ID: 1621243
[TBL] [Abstract][Full Text] [Related]
8. Effects of fibrin on the secretion of plasminogen activator inhibitor-1 from endothelial cells and on protein kinase C.
Fukao H; Matsumoto H; Ueshima S; Okada K; Matsuo O
Life Sci; 1995; 57(13):1267-76. PubMed ID: 7674818
[TBL] [Abstract][Full Text] [Related]
9. Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers.
Ramakrishnan V; Sinicropi DV; Dere R; Darbonne WC; Bechtol KB; Baker JB
J Biol Chem; 1990 Feb; 265(5):2755-62. PubMed ID: 2105933
[TBL] [Abstract][Full Text] [Related]
10. Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1.
Russell ME; Quertermous T; Declerck PJ; Collen D; Haber E; Homcy CJ
J Biol Chem; 1990 Feb; 265(5):2569-75. PubMed ID: 2105930
[TBL] [Abstract][Full Text] [Related]
11. Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells.
Rosenfeld L; Kuo A; Hirsh J; Klugherz B; Gardell SJ; Cines DB; Barnathan ES
Blood; 1992 Sep; 80(6):1486-95. PubMed ID: 1520875
[TBL] [Abstract][Full Text] [Related]
12. Fibrin induction of tissue plasminogen activator expression in corneal endothelial cells in vitro.
Ramsby ML; Kreutzer DL
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3207-19. PubMed ID: 7691778
[TBL] [Abstract][Full Text] [Related]
13. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells.
Thompson EA; Nelles L; Collen D
Eur J Biochem; 1991 Nov; 201(3):627-32. PubMed ID: 1935958
[TBL] [Abstract][Full Text] [Related]
14. Effect of fibrin on endothelial cell production of prostacyclin and tissue plasminogen activator.
Kaplan KL; Mather T; DeMarco L; Solomon S
Arteriosclerosis; 1989; 9(1):43-9. PubMed ID: 2492187
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals.
Shatos MA; Doherty JM; Orfeo T; Hoak JC; Collen D; Stump DC
J Biol Chem; 1992 Jan; 267(1):597-601. PubMed ID: 1730619
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma modulates the fibrinolytic response in cultured human endothelial cells.
Arnman V; Stemme S; Rymo L; Risberg B
Thromb Res; 1995 Mar; 77(5):431-40. PubMed ID: 7778058
[TBL] [Abstract][Full Text] [Related]
17. Stimulation by retinoids of tissue-type plasminogen activator secretion in cultured human endothelial cells: relations of structure to effect.
Bulens F; Nelles L; Van den Panhuyzen N; Collen D
J Cardiovasc Pharmacol; 1992 Apr; 19(4):508-14. PubMed ID: 1380592
[TBL] [Abstract][Full Text] [Related]
18. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells.
Yamamoto C; Kaji T; Sakamoto M; Kozuka H; Koizumi F
Thromb Res; 1994 Apr; 74(2):163-8. PubMed ID: 8029817
[TBL] [Abstract][Full Text] [Related]
19. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
[TBL] [Abstract][Full Text] [Related]
20. Carbazochrome sodium sulphonate (AC-17) decreases the accumulation of tissue-type plasminogen activator in culture medium of human umbilical vein endothelial cells.
Matsumoto Y; Hayashi T; Hayakawa Y; Shinbo M; Niiya K; Sakuragawa N
Blood Coagul Fibrinolysis; 1995 May; 6(3):233-8. PubMed ID: 7654937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
